Sometimes, you take the gifts the market gives you. This is how I felt when I saw shares of Commonwealth REIT
jump so sharply in late February.
CWH data by YCharts
When I first purchased shares of Commonwealth for my
Dividend Growth Portfolio
, it was a stock that had been left for dead. Wall Street hated management, earnings had been disappointing for months, and the stock had lost nearly half its value over the previous two years.
But the REIT was cheap, trading at barely half its book value, and the share price looked to have finally stabilized. In my opinion, it seemed a decent contrarian bet for the next 2-5 years. The value of the underlying properties limited my downside risk, and I could continue to collect the dividend indefinitely.
There was always the possibility that the dividend would be cut—and in fact it was late in 2012. But even at the reduced yield, Commonwealth paid a better dividend than most of the alternatives. All told, Commonwealth seemed like a very reasonable investment. No matter how incompetent management could be, I believed it would be hard to lose with a portfolio of high-quality properties selling for well below their book value. Or so I thought…
You can never put it past management to do precisely the wrong thing at the wrong time. Rather than buy low and sell high, public companies have a bad tendency to do the opposite. They often buy back their shares when prices are high and issue new shares when prices are low — a destruction of shareholder wealth that should be unforgivable.
to massively dilute shareholders with a new offering of more than 30 million shares. Not only was this a dilution of nearly 40%, but the shares were being offered at a 43% discount to book value.
While I was pondering selling, two large shareholders, Corvex Management and Related Fund Management, sued the company for breach of fiduciary duty and
offered to buy the company for $27 per share
. Corvex and Related claimed that an independent assessment of Commonwealth’s properties put the value of the REIT at $40 per share. The stock jumped.
Maybe Commonwealth is worth that, and maybe it isn’t. But in a situation like this, it generally doesn’t make sense to find out. At time of writing on March 5, Commonwealth is trading for a little less than $24 per share. If the Corvex and Related offer at $27 was approved, investors would be looking at 12-13% gains in a very short period of time. But what if it isn’t approved?